<code id='64206CDC15'></code><style id='64206CDC15'></style>
      • <acronym id='64206CDC15'></acronym>
      <center id='64206CDC15'><center id='64206CDC15'><tfoot id='64206CDC15'></tfoot></center><abbr id='64206CDC15'><dir id='64206CDC15'><tfoot id='64206CDC15'></tfoot><noframes id='64206CDC15'>
      • <optgroup id='64206CDC15'><strike id='64206CDC15'><sup id='64206CDC15'></sup></strike><code id='64206CDC15'></code></optgroup>
        5. <b id='64206CDC15'><label id='64206CDC15'><select id='64206CDC15'><dt id='64206CDC15'><span id='64206CDC15'></span></dt></select></label></b><u id='64206CDC15'></u>
          <i id='64206CDC15'><strike id='64206CDC15'><tt id='64206CDC15'><pre id='64206CDC15'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / knowledge / focus      
           
     
           
      
          focus 
           
      
           
      
           
       2025-10-04 11:20:01 
   
      
           
      
           
                        
          focus  
          
                                   
                 
                                      author：explore   
                                        
                                      
                                      Page View：6722
                                  
                                    
          
                                   
          Editor’s note: A recording of the event is embedded below.
          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.
          advertisement
          Featured Speakers
          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Medicare Advantage beneficiaries sue Humana over algorithm use
                                
                            
          Next article：  
                                      
                                          23andMe had bad news about my health. I wish a person had delivered it
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles